Boston Scientific Corporation (BSX) Stock Grade

About Boston Scientific Corporation's fundamentals

Boston Scientific is a large-cap medical device company with a market capitalization of $141.2 billion that has demonstrated strong revenue expansion, growing 19.9% year-over-year. The company maintains a net profit margin of 14.4%, indicating solid profitability relative to its sales, though its return on equity of 11.9% is modest for the sector. Trading at a P/E ratio of 48.9, the valuation reflects market expectations for continued growth, though it is elevated relative to historical norms. The company does not currently pay a dividend, suggesting it is reinvesting earnings into operations and growth initiatives.